Regulatory & Legal

New federal rules make buying fake reviews a costly crime. Businesses now face $50,000+ fines per violation and digital ruin from AI-powered crackdowns.

With FDA clearance, Zeto New Wave™ promises to slash EEG wait times and ease staff shortages, making critical brain health data more accessible.

After a period of limited availability, the Ellipsys Vascular Access System is set for a 2026 relaunch, promising a less invasive option for dialysis patients.

With FDA clearance for clinical trials, CanWell Pharma’s novel CAN016 ADC brings a two-pronged attack against drug-resistant HER2-positive cancers.

AvenCell has dosed the first patient with AVC-203, a novel allogeneic CAR-T therapy, aiming to make advanced cancer treatment more accessible and effective.

Scientists propose a unifying model combining 'viral mimicry' and 'cancer dark matter,' potentially revolutionizing how our immune system recognizes and fights tumors.

Arcosa sheds its cyclical barge business for $450M to double down on high-growth construction materials, signaling a major shift to capitalize on U.S. infrastructure.

Investment firm Birchtree Investments makes a bold leap into decentralized finance, acquiring Web3 innovator Digital Motion in a $20 million all-stock deal.

OnPath Federal Credit Union finalizes its purchase of Heritage Bank, marking a major shift in local banking and leaving shareholders with a variable payout.

The Supreme Court's final word on two Agilent patents ends a major legal battle, promising to accelerate gene-editing research and therapies.

Amid soaring debt and policy uncertainty, a top financial industry leader calls for urgent action to address a growing crisis in American household finance.

The firm is among the first to offer actively managed ETF share classes of mutual funds, signaling a major shift in the investment product landscape.

A new Black Health and Social Services Hub in Peel, backed by a $25M investment, aims to dismantle systemic barriers with a revolutionary integrated care model.

A new rail partnership in metro Atlanta aims to unlock freight capacity, but it also signals a larger strategic play for Norfolk Southern's future.

Millions of parasitic wasps are California's front line against a disease threatening its $3.4B citrus industry. The real battle may be in your backyard.

Marking 40 years, NYC's Javits Center unveils its 'Javits on the Hudson' rebrand, highlighting its evolution into a sustainable, civic, and economic hub.

Expanded Medicare payment for RefleXion's SCINTIX therapy removes major financial hurdles, opening doors for advanced cancer care in community centers.

Texan by Nature names its 2026 Conservation Wranglers, backing innovative projects from desert creeks to urban cemeteries to secure the state's future.

Investors tendered over four times the shares sought in a Morgan Stanley China fund buyback, a stark signal of sentiment on Chinese equities.

As generative AI invents facts and misattributes sources, a new industry of 'credibility defense' is emerging to protect brands from digital distortion.